×
戻る Agenda
Session 4 : Direction to Review of Regenerative Medicine Products - What we should/can do to obtain “True approval”-
Session Chair(s)
Kiyoshi Okada, MD, PhD
Vice Director, Medical Ctr for Translational Research,Dept of Medical Innovation
Osaka University Hospital, Japan
Sumimasa Nagai, MD, PhD
Institute for Advancement of Clinical and Translational Science(iACT)
Kyoto University Hospital, Japan
Speaker(s)
Shigeru Miyagawa
Osaka University, Japan
Professer, Cardiovascular surgery, Osaka University Hospital
Yoji Sato, PhD
National Institute of Health Sciences, Japan
Head, Division of Drugs